GO:0016514 SWI/SNF complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016514 defines the SWI/SNF complex, an ATP-dependent chromatin remodeling machine of 8 to 14 subunits built around a conserved ATPase such as SMARCA4/BRG1.
• SWI/SNF complexes are modular and assembled from core, accessory, and variant subunits, enabling combinatorial diversity across cell types.
• They regulate transcription, DNA repair, replication, and genome stability by sliding and evicting nucleosomes.
• SWI/SNF is mechanoregulated and inhibits YAP/TAZ signaling, linking chromatin remodeling to mechanical cues.
• Mutations in SWI/SNF subunits are frequent in cancer, including gynecologic and breast cancers, making the complex a therapeutic target.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect subunit-specific functions and vulnerabilities.
Description
The SWI/SNF complex (GO:0016514) is a multi-subunit, ATP-dependent chromatin remodeling assembly that controls nucleosome positioning and DNA accessibility. It was originally identified in yeast through switching (SWI) and sucrose non-fermenting (SNF) mutants, and its mammalian counterpart is often called BAF (BRG1-associated factor). The complex contains 8 to 14 proteins, including both conserved core subunits and nonconserved accessory subunits, and it is defined by the presence of an ATPase such as yeast SNF2 or mammalian SMARCA4/BRG1. Because of its central role in gene regulation, SWI/SNF is essential for development, differentiation, and tissue homeostasis. Dysregulation of SWI/SNF is increasingly recognized as a driver of human disease, especially cancer, where subunit mutations occur at high frequency. Beyond transcription, the complex contributes to DNA repair, replication fork progression, and resolution of transcription-replication conflicts. Its mechanosensitive regulation of YAP/TAZ further connects chromatin remodeling to cellular mechanics and tissue architecture. These diverse functions make SWI/SNF a rich area for basic and translational research. For researchers, GO:0016514 provides a precise ontology handle for annotating genes, proteins, and complexes in chromatin biology. Understanding its composition, assembly, and regulation is critical for designing experiments that probe subunit-specific roles in health and disease.
SWI/SNF complex At A Glance
| GO ID | GO:0016514 |
|---|---|
| GO term | SWI/SNF complex |
| Ontology | cellular_component |
| Synonym | SWI-SNF complex |
| Major function | ATP-dependent chromatin remodeling, nucleosome sliding and eviction, regulation of transcription, DNA repair, and replication |
| Subunit number | 8 to 14 proteins, including conserved core and nonconserved accessory subunits |
| Defining ATPase | Yeast SNF2 or mammalian SMARCA4/BAF190A/BRG1, or orthologs |
| Mechanoregulation | Inhibits YAP/TAZ in response to mechanical cues |
| Disease relevance | Frequently mutated in cancer, including gynecologic and breast cancers |
What Is GO:0016514?
GO:0016514 (SWI/SNF complex) is a cellular component term describing a SWI/SNF-type chromatin remodeling complex that contains 8 to 14 proteins, including both conserved core components and nonconserved accessory components. The complex must contain the ATPase product of the yeast SNF2 gene or the mammalian SMARCA4/BAF190A/BRG1 gene, or an ortholog thereof. This definition captures the conserved catalytic core and the variable subunits that confer functional diversity.
Why Is SWI/SNF complex Important in Cell Biology?
The SWI/SNF complex is a master regulator of chromatin architecture and gene expression, and its dysfunction is causally linked to cancer, developmental disorders, and other diseases. Because it is mutated in a large fraction of human cancers, SWI/SNF subunits are attractive biomarkers and therapeutic targets. Understanding its assembly and regulation is essential for interpreting disease-associated mutations and for developing targeted therapies.
• SWI/SNF mutations are among the most common epigenetic alterations in cancer, including ovarian, uterine, and breast cancers.
• The complex is required for DNA repair and genome stability, and its loss leads to replication stress and R-loop accumulation.
• SWI/SNF integrates mechanical signals by inhibiting YAP/TAZ, affecting tissue growth and differentiation.
• Subunit-specific mutations can create synthetic lethal vulnerabilities, offering therapeutic opportunities.
• SWI/SNF remodeling is essential for developmental gene expression programs and cell fate decisions.
• Its modular assembly allows combinatorial diversity, which complicates functional annotation but enables tissue-specific roles.
• Loss of SWI/SNF subunits can alter enhancer accessibility and oncogenic transcription.
• SWI/SNF is a target for small-molecule inhibitors and degraders in preclinical studies.
• Understanding SWI/SNF function requires integrating genomics, proteomics, and imaging approaches.
• CRISPR-based models are critical for dissecting subunit-specific functions and validating therapeutic targets.
SWI/SNF complex: Biological Process, Structure, and Molecular Mechanism
What Happens During SWI/SNF complex?
In simple terms: SWI/SNF acts like a molecular motor that slides or removes nucleosomes to open or close DNA, controlling which genes are turned on or off.
The SWI/SNF complex uses ATP hydrolysis to disrupt histone-DNA contacts, sliding nucleosomes along DNA and evicting them from regulatory regions. This remodeling activity is required for transcription factor access to enhancers and promoters, and it influences gene expression programs. Beyond transcription, SWI/SNF is recruited to sites of DNA damage and replication stress, where it promotes repair and fork progression. It also resolves R-loop-mediated transcription-replication conflicts, safeguarding genome integrity.
Nucleosome Sliding and Eviction
In simple terms: The complex physically pushes or removes nucleosomes to expose DNA sequences.
ATP-dependent remodeling by SWI/SNF involves translocation of the ATPase subunit along DNA, which generates torsional strain that shifts nucleosomes. This activity is modulated by the composition of accessory subunits, which dictate targeting to specific genomic loci. Nucleosome eviction at promoters and enhancers facilitates binding of transcription factors and RNA polymerase II.
Transcription Regulation
In simple terms: SWI/SNF helps turn genes on or off by controlling DNA accessibility.
SWI/SNF is recruited by sequence-specific transcription factors and contributes to both activation and repression of target genes. Its loss leads to widespread changes in chromatin accessibility and gene expression, often favoring oncogenic programs. In cancer, SWI/SNF mutations can disrupt enhancer landscapes and alter lineage-specific transcription.
Genome Stability and DNA Repair
In simple terms: SWI/SNF helps fix DNA damage and keeps replication running smoothly.
SWI/SNF promotes homologous recombination and non-homologous end joining by facilitating access of repair factors to damaged chromatin. It also helps resolve R-loops that form during transcription, preventing transcription-replication conflicts and DNA breaks. Loss of SWI/SNF subunits leads to replication stress and sensitivity to DNA-damaging agents.
Mechanoregulation and YAP/TAZ Inhibition
In simple terms: SWI/SNF senses mechanical forces and puts brakes on growth-promoting signals.
The SWI/SNF complex is mechanoregulated and inhibits the YAP/TAZ transcriptional coactivators, linking chromatin remodeling to mechanical cues from the extracellular matrix. This inhibition is important for controlling organ size and preventing aberrant proliferation. Disruption of this axis may contribute to cancer and fibrosis.
Key Genes Involved in GO:0016514 SWI/SNF complex
The following genes encode core and accessory subunits of the SWI/SNF complex, as well as related regulatory proteins, and are frequently studied in chromatin biology and cancer research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SMARCA4 | ATPase catalytic subunit (BRG1) | Most frequently mutated SWI/SNF subunit in cancer; target for inhibitors |
| SMARCA2 | ATPase catalytic subunit (BRM) | Synthetic lethal with SMARCA4 mutations; therapeutic target |
| SMARCB1 | Core subunit (SNF5/INI1) | Biallelic inactivation in malignant rhabdoid tumors and epithelioid sarcomas |
| ARID1A | Accessory subunit (BAF250A) | Frequently mutated in ovarian clear cell and endometrioid cancers |
| ARID1B | Accessory subunit (BAF250B) | Synthetic lethal with ARID1A loss; potential target |
| PBRM1 | Accessory subunit (BAF180) | Mutated in renal cell carcinoma; biomarker for immunotherapy |
| SMARCC1 | Core subunit (BAF155) | Essential for complex integrity; studied in development |
| SMARCC2 | Core subunit (BAF170) | Core scaffold; mutations in cancer and neurodevelopmental disorders |
| SMARCD1 | Core subunit (BAF60A) | Modulates complex activity; involved in differentiation |
| SMARCD2 | Core subunit (BAF60B) | Roles in hematopoiesis; mutations in leukemia |
| SMARCD3 | Core subunit (BAF60C) | Muscle and heart development; variant complexes |
| SMARCE1 | Core subunit (BAF57) | DNA-binding subunit; mutations in meningioma |
| ACTL6A | Accessory subunit (BAF53A) | Actin-related; regulates complex assembly |
| ACTL6B | Accessory subunit (BAF53B) | Neuronal variant; neurodevelopmental roles |
| BCL7A | Accessory subunit | Mutated in lymphoma; part of BAF complex |
| BCL7B | Accessory subunit | Cohesin-like functions; developmental roles |
| BCL7C | Accessory subunit | Less characterized; potential tumor suppressor |
| SS18 | Accessory subunit (SS18/SSXT) | Translocated in synovial sarcoma; fusion oncoprotein |
How Is SWI/SNF complex Regulated?
SWI/SNF complex activity is regulated at multiple levels. Its assembly is modular, with core subunits forming a stable scaffold and accessory subunits exchanging to create variant complexes with distinct genomic targeting. Post-translational modifications of subunits, including phosphorylation and ubiquitination, influence complex stability and recruitment. Mechanical cues from the extracellular matrix regulate SWI/SNF function, leading to inhibition of YAP/TAZ. Additionally, SWI/SNF activity is coupled to DNA damage signaling and replication stress responses, which can alter its recruitment to chromatin. In cancer, mutations in subunits often lead to loss of function or dominant-negative effects, disrupting normal regulation.
SWI/SNF complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ARID1A | Ovarian clear cell carcinoma, endometrioid cancer | ARID1A knockout ovarian cancer cell lines; xenograft models |
| SMARCA4 | Lung adenocarcinoma, Coffin-Siris syndrome | SMARCA4 knockout lung cancer cells; patient-derived xenografts |
| SMARCB1 | Malignant rhabdoid tumor, epithelioid sarcoma | SMARCB1 knockout rhabdoid tumor lines; CRISPR knock-in of patient mutations |
| PBRM1 | Renal cell carcinoma | PBRM1 knockout renal cancer cells; immunotherapy models |
| SS18 | Synovial sarcoma | SS18-SSX fusion knock-in mesenchymal stem cells |
SWI/SNF in Cancer
SWI/SNF subunits are mutated in approximately 20% of human cancers, making the complex one of the most frequently altered epigenetic regulators. ARID1A mutations are common in ovarian clear cell carcinoma and endometrioid cancers, while SMARCA4 mutations occur in lung adenocarcinoma and other malignancies. SMARCB1 loss defines malignant rhabdoid tumors and epithelioid sarcomas. These mutations often lead to altered chromatin accessibility and oncogenic transcription. Targeting residual SWI/SNF activity, such as SMARCA2 in SMARCA4-deficient tumors, is a promising therapeutic strategy.
SWI/SNF in Gynecologic and Breast Cancers
Gynecologic cancers, including ovarian and uterine cancers, exhibit frequent mutations in ARID1A, SMARCA4, and other SWI/SNF genes. In breast cancer, SWI/SNF subunit mutations are found across subtypes and are associated with distinct clinical outcomes. Loss of ARID1A or SMARCA4 can disrupt estrogen receptor signaling and confer resistance to endocrine therapy. Research models using CRISPR knockout of these subunits are helping to uncover subtype-specific vulnerabilities.
SWI/SNF in Genome Instability and DNA Repair Defects
SWI/SNF deficiency leads to impaired DNA repair and accumulation of R-loops, causing transcription-replication conflicts and DNA breaks. This genome instability may contribute to tumor initiation and progression. Cells lacking SWI/SNF subunits are sensitive to DNA-damaging agents and poly(ADP-ribose) polymerase inhibitors, suggesting therapeutic opportunities.
SWI/SNF in Developmental Disorders
Germline mutations in SWI/SNF subunits, such as SMARCA4 and SMARCB1, cause Coffin-Siris syndrome and Nicolaides-Baraitser syndrome, characterized by intellectual disability and developmental anomalies. These disorders highlight the essential role of SWI/SNF in neural development and differentiation.
From SWI/SNF complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of SWI/SNF subunit loss on gene expression? | CRISPR knockout of ARID1A or SMARCA4 in cancer cell lines followed by RNA-seq |
| How do point mutations in SMARCA4 affect ATPase activity? | CRISPR point mutation knock-in of catalytic-dead SMARCA4 |
| What is the role of SWI/SNF in DNA repair? | Knockout of SMARCB1 and assessment of R-loop resolution and replication stress |
| Can SMARCA2 be targeted in SMARCA4-deficient tumors? | SMARCA4 knockout cells with inducible SMARCA2 knockdown |
| How does SWI/SNF mechanoregulate YAP/TAZ? | Knockout of core subunits in cells grown on substrates of varying stiffness |
| What is the impact of SWI/SNF overexpression? | Overexpression of wild-type or mutant SMARCA4 in cancer cells |
How to Study the SWI/SNF complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Assessing transcriptional consequences of SWI/SNF loss |
| ATAC-seq | Chromatin accessibility | Mapping open chromatin after subunit knockout |
| ChIP-seq | Protein-DNA interactions | Localizing SWI/SNF subunits and histone marks |
| Mass spectrometry | Protein complex composition | Identifying subunit interactions and assembly |
| DRIP-seq | R-loop formation | Detecting transcription-replication conflicts |
| Comet assay | DNA breaks | Measuring genome instability in knockout cells |
| Live-cell imaging | Dynamic recruitment | Tracking SWI/SNF at damage sites |
| CRISPR screening | Gene essentiality and synthetic lethality | Identifying vulnerabilities in SWI/SNF-mutant cancers |
Genomic and Transcriptomic Profiling
RNA-seq and ATAC-seq are used to measure changes in gene expression and chromatin accessibility upon SWI/SNF perturbation. These methods reveal how subunit loss alters enhancer landscapes and transcription factor binding. Integrating with ChIP-seq for histone modifications provides a comprehensive view of SWI/SNF function.
Proteomic and Biochemical Approaches
Affinity purification coupled with mass spectrometry identifies SWI/SNF subunit composition and assembly intermediates. Immunoprecipitation and western blotting confirm interactions and complex integrity. These approaches are essential for defining variant complexes and their stoichiometry.
Imaging and Chromatin Dynamics
Live-cell imaging of fluorescently tagged subunits allows tracking of SWI/SNF recruitment to DNA damage sites and replication forks. Single-molecule imaging can visualize nucleosome remodeling in real time. These techniques provide spatial and temporal resolution of complex activity.
Functional Assays for Genome Stability
Comet assays, gamma-H2AX staining, and R-loop detection by DRIP-seq assess DNA damage and replication stress in SWI/SNF-deficient cells. These assays link complex function to genome maintenance.
How CRISPR Can Be Used to Study GO:0016514 SWI/SNF complex
Knockout
CRISPR knockout of SWI/SNF subunits such as ARID1A, SMARCA4, or SMARCB1 is widely used to model loss-of-function mutations observed in cancer. These models reveal changes in chromatin accessibility, gene expression, and sensitivity to targeted therapies. Knockout of core subunits can disrupt complex integrity, while accessory subunit knockouts may retain partial function.
Point Mutation
CRISPR point mutation knock-in allows precise introduction of cancer-associated missense mutations, such as those in the SMARCA4 ATPase domain, to study their impact on enzymatic activity and complex assembly. These models help distinguish loss-of-function from dominant-negative effects.
Knock-in
Knock-in of epitope tags or fluorescent reporters into endogenous SWI/SNF subunit loci enables tracking of protein localization and interactions without overexpression artifacts. Knock-in of patient-derived mutations into cell lines provides isogenic models for functional studies.
Overexpression
Overexpression of wild-type or mutant SWI/SNF subunits is used to test gain-of-function effects and to study dominant-negative mechanisms. This approach can also rescue knockout phenotypes to confirm specificity.
How EDITGENE Supports SWI/SNF complex Research
Researchers studying SWI/SNF complex-related genes often need to determine whether a candidate gene is causally involved in chromatin remodeling, cancer progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for SWI/SNF complex research.
Frequently Asked Questions About SWI/SNF complex
What is the SWI/SNF complex?
The SWI/SNF complex is an ATP-dependent chromatin remodeling machine that contains 8 to 14 proteins, including a conserved ATPase such as SMARCA4/BRG1, and regulates gene expression, DNA repair, and replication.
What genes are involved in the SWI/SNF complex?
Key genes include SMARCA4, SMARCA2, ARID1A, ARID1B, SMARCB1, PBRM1, SMARCC1, SMARCC2, and SS18, among others.
What is the function of GO:0016514?
GO:0016514 is the Gene Ontology term for the SWI/SNF complex, describing its role as a chromatin remodeling complex that slides and evicts nucleosomes.
How is SWI/SNF complex regulated?
It is regulated by subunit exchange, post-translational modifications, mechanical cues, and DNA damage signaling.
What diseases are associated with SWI/SNF mutations?
SWI/SNF mutations are linked to many cancers, including ovarian, uterine, breast, lung, and renal cancers, as well as developmental disorders like Coffin-Siris syndrome.
How can I study SWI/SNF complex in the lab?
Common methods include CRISPR knockout, RNA-seq, ATAC-seq, ChIP-seq, proteomics, and imaging to assess chromatin remodeling and gene expression.
What is the role of SMARCA4 in SWI/SNF?
SMARCA4 is the ATPase catalytic subunit that drives nucleosome sliding and eviction, and it is frequently mutated in cancer.
Why is SWI/SNF important in cancer?
SWI/SNF subunits are mutated in about 20% of cancers, making the complex a major tumor suppressor and therapeutic target.
What is the difference between BAF and PBAF complexes?
BAF and PBAF are variant SWI/SNF complexes that share core subunits but differ in accessory subunits like ARID1A/ARID1B and PBRM1, leading to distinct genomic targeting.
Can CRISPR be used to model SWI/SNF mutations?
Yes, CRISPR knockout, point mutation knock-in, and tagged knock-in are widely used to model SWI/SNF mutations and study their effects.
Conclusion
The SWI/SNF complex (GO:0016514) is a central regulator of chromatin structure and genome function, with critical roles in transcription, DNA repair, and mechanotransduction. Its frequent mutation in cancer and developmental disorders underscores its clinical importance. Continued research using advanced CRISPR models and multi-omics approaches will further illuminate subunit-specific functions and reveal new therapeutic opportunities.
References
- 1. Mittal P et al.. 2020. The SWI/SNF complex in cancer - biology, biomarkers and therapy.. Nat Rev Clin Oncol 17(7):435-448 PMID: 32303701
- 2. Chang L et al.. 2018. The SWI/SNF complex is a mechanoregulated inhibitor of YAP and TAZ.. Nature 563(7730):265-269 PMID: 30401838
- 3. Ribeiro-Silva C et al.. 2019. SWI/SNF: Complex complexes in genome stability and cancer.. DNA Repair (Amst) 77:87-95 PMID: 30897376
- 4. Bayona-Feliu A et al.. 2021. The SWI/SNF chromatin remodeling complex helps resolve R-loop-mediated transcription-replication conflicts.. Nat Genet 53(7):1050-1063 PMID: 33986538
- 5. Wang Y et al.. 2020. SWI/SNF Complex Mutations in Gynecologic Cancers: Molecular Mechanisms and Models.. Annu Rev Pathol 15:467-492 PMID: 31977292
- 6. Reddy D et al.. 2023. (mis)-Targeting of SWI/SNF complex(es) in cancer.. Cancer Metastasis Rev 42(2):455-470 PMID: 37093326
- 7. Mashtalir N et al.. 2018. Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes.. Cell 175(5):1272-1288.e20 PMID: 30343899
- 8. Li K et al.. 2024. Research progress of SWI/SNF complex in breast cancer.. Epigenetics Chromatin 17(1):4 PMID: 38365747
